Dietary Impact on Sleep, Rhythms and Related Physiology
Inverkan av Kost pa Dygnsrytmer Och Amnesomsattning
1 other identifier
interventional
24
1 country
1
Brief Summary
Sleep and metabolism are closely interconnected, and emerging evidence suggests that dietary composition may influence both sleep quality and key physiological functions such as glucose regulation, cardiovascular activity, and hormonal signaling. This study aims to investigate how a Western-style unhealthy diet versus a healthier, fiber-rich diet affects objective and subjective sleep measures, 24-hour physiological parameters, and a range of biomarkers related to cardiometabolic, neurodegenerative, and gut microbial function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2025
CompletedFirst Posted
Study publicly available on registry
August 22, 2025
CompletedStudy Start
First participant enrolled
September 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
February 4, 2026
February 1, 2026
1.9 years
July 4, 2025
February 3, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Sleep Architecture and Neurophysiological Features
Objective registration and analysis of sleep, based on polysomnography or validated wearable devices to capture macrosleep, spectral and microsleep features.
Up to 9 nights on each diet
Change in 24-Hour Heart Rate Variability (HRV)
Continuous measurement of HRV, using a wearable device, focused on the metric Root Mean Square of the Successive Differences (RMSD); additional metrics (Standard Deviation of NN intervals (SDNN), low frequency to high frequency (LF/HF) ratio) analyzed for exploratory purposes.
Up to 9 days on each diet
Secondary Outcomes (24)
24-Hour Heart Rate (HR)
Up to 9 days on each diet
Heart Rate Response to Standardized Stair Stepping
Baseline and day 7-9 of each diet period
Morning-to-Evening and 24-h blood pressure (BP)
Up to 9 days on each diet
24 Hour Continuous Glucose Levels
Up to 9 days on each diet
Levels of Blood-based Biomarkers
Up to 9 days on each diet
- +19 more secondary outcomes
Study Arms (2)
Healthy diet
EXPERIMENTAL'Low-fat dietary intervention' to be administered to participants
Unhealthier diet
EXPERIMENTAL'High-fat dietary intervention' to be administered to participants
Interventions
Low-fat diet for approximately 1 week, preceding in-lab study period (approximately 2 days) under standardized conditions (total dietary exposure up to 9-10 days).
High-fat diet for approximately 1 week, preceding in-lab study period (approximately 2 days) under standardized conditions (total dietary exposure up to 9-10 days).
Eligibility Criteria
You may qualify if:
- Age 18-32 yr
- Healthy (self-reported) and not on chronic medication
- BMI 18-27 kg/m2 (and waist circumference \<102 cm), and weight stable (less than 5% body weight change in the past 6 months)
- Non-smoker and non-nicotine user
- Regular sleep-wake pattern, with sleep duration of 7-9.25 hrs per night
- Regular exercise habits the last 2 months
- Regular daily meal pattern with 3 main meals
You may not qualify if:
- Major or chronic illness, e.g. diabetes, renal disease or inflammatory bowel disease
- Current or history of endocrine or metabolic disorders
- Psychiatric or neurological disorders (e.g. bipolar disorder, epilepsy)
- Frequent gastrointestinal symptoms
- Chronic medication
- Any sleep disorder (including recent or chronic symptoms of insomnia)
- Shift work in the preceding three months or for a long duration
- Extreme chronotype or physical activity patterns
- Time travel over two time zones in the preceding month
- Too much weight gain or weight loss in the preceding 6 months (±5% body weight in past 6 months)
- Any issues with or allergies against the provided food items
- Recent major dietary changes or adoption of specific dietary regimens
- Women who are pregnant, breastfeeding, or planning to become pregnant during the study period.
- Use of illicit drugs or substances of abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uppsala biomedical center
Uppsala, 75324, Sweden
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan Cedernaes, MD, PhD
Uppsala University, Sweden
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- In the crossover condition, participants will not be briefed about what diet they will receive before the actual onset of any of the two dietary interventions
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2025
First Posted
August 22, 2025
Study Start
September 22, 2025
Primary Completion (Estimated)
July 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
February 4, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share